These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2901850)

  • 1. Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.
    Sidi Y; Panet C; Wasserman L; Cyjon A; Novogrodsky A; Nordenberg J
    Br J Cancer; 1988 Jul; 58(1):61-3. PubMed ID: 2901850
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
    Sokoloski JA; Blair OC; Sartorelli AC
    Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA; Sartorelli AC
    Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of IMP dehydrogenase prevent sindbis virus replication and reduce GTP levels in Aedes albopictus cells.
    Malinoski F; Stollar V
    Virology; 1981 Apr; 110(2):281-9. PubMed ID: 6111860
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation and reduction of intracellular GTP levels in HL-60 and U937 cells upon treatment with IMP dehydrogenase inhibitors.
    Inai K; Tsutani H; Yamauchi T; Nakamura T; Ueda T
    Adv Exp Med Biol; 1998; 431():549-53. PubMed ID: 9598126
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective guanosine phosphate deficiency in hepatoma cells induced by inhibitors of IMP dehydrogenase.
    Kaiser WA; Herrmann B; Keppler DO
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1503-10. PubMed ID: 6108911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the effects of rT3 and IMP dehydrogenase inhibitors on normal and trisomic 21 lymphocyte cultures.
    Peeters M; Réthoré MO; de Kermadec S; Lejeune J
    Ann Genet; 1989; 32(4):211-3. PubMed ID: 2575364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurin.
    Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
    Exp Cell Res; 1990 Mar; 187(1):47-53. PubMed ID: 1967583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological effects of inhibition of guanine nucleotide synthesis by mycophenolic acid in cultured neuroblastoma cells.
    Cass CE; Lowe JK; Manchak JM; Henderson JF
    Cancer Res; 1977 Sep; 37(9):3314-20. PubMed ID: 195725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition and induction of phenotypic alterations by tiazofurin: differential effects on MCF-7 breast cancer and HBL-100 breast cell lines.
    Sidi Y; Beery E; Panet C; Wasserman L; Novogrodsky A; Nordenberg J
    Eur J Cancer Clin Oncol; 1989 May; 25(5):883-9. PubMed ID: 2737221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis.
    Catapano CV; Dayton JS; Mitchell BS; Fernandes DJ
    Mol Pharmacol; 1995 May; 47(5):948-55. PubMed ID: 7746281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMP dehydrogenase from the intracellular parasitic protozoan Eimeria tenella and its inhibition by mycophenolic acid.
    Hupe DJ; Azzolina BA; Behrens ND
    J Biol Chem; 1986 Jun; 261(18):8363-9. PubMed ID: 2873141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increases in purine excretion and rate of synthesis by drugs inhibiting IMP dehydrogenase or adenylosuccinate synthetase activities.
    Willis RC; Seegmiller JE
    Adv Exp Med Biol; 1979; 122B():237-41. PubMed ID: 44644
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity.
    Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
    Cell Growth Differ; 1990 Jun; 1(6):259-70. PubMed ID: 1980599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase.
    Yu J; Lemas V; Page T; Connor JD; Yu AL
    Cancer Res; 1989 Oct; 49(20):5555-60. PubMed ID: 2571408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones.
    Page JD; Chaney SG; Hall IH; Lee KH; Holbrook DJ
    Biochim Biophys Acta; 1987 Nov; 926(2):186-94. PubMed ID: 2889474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct target sites on IMP dehydrogenase in chemotherapy.
    Yamada Y; Natsumeda Y; Yamaji Y; Weber G
    Adv Exp Med Biol; 1989; 253B():57-63. PubMed ID: 2575352
    [No Abstract]   [Full Text] [Related]  

  • 19. Guanosine-5'-triphosphate increases in red blood cells of heart transplant recipients treated with mycophenolate mofetil.
    Griesmacher A; Weigel G; Seebacher G; Müller MM
    Adv Exp Med Biol; 2000; 486():139-43. PubMed ID: 11783471
    [No Abstract]   [Full Text] [Related]  

  • 20. Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and virazole.
    Lowe JK; Brox L; Henderson JF
    Cancer Res; 1977 Mar; 37(3):736-43. PubMed ID: 837373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.